Sidley is representing Venus Medtech (Hangzhou) Inc., a leading, innovative Chinese structural heart disease treatment company, in the acquisition of Cardiovalve Ltd., an Israel-based, pioneering transcatheter mitral and tricuspid valve treatment company. Continue reading

See all Member News